IRVINE, Calif.--(BUSINESS WIRE)--eGene, Inc. (OTCBB: EGEI), developer of a high-performance genetic analysis technology, announced today that it has been acquired by QIAGEN North American Holdings, Inc., a wholly-owned subsidiary of QIAGEN N.V. (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA), the world’s leading provider of sample and assay technologies for research in life sciences, applied testing and molecular diagnostics. This transaction was publicly announced on April 12, 2007.
